GM1 GANGLIOSIDE TO ANNEXIN V MICROPARTICLE POLYPEPTIDE RATIO FOR BIOLOGICAL MONITORING
    26.
    发明公开
    GM1 GANGLIOSIDE TO ANNEXIN V MICROPARTICLE POLYPEPTIDE RATIO FOR BIOLOGICAL MONITORING 有权
    的关系神经节苷脂MIKROPARTIKELPOLYPEPTID和Annexin V MIKROPARTIKELPOLYPEPTID FOR生物监测

    公开(公告)号:EP2785734A4

    公开(公告)日:2015-11-11

    申请号:EP12853105

    申请日:2012-11-30

    IPC分类号: C07K14/47 C12Q1/25 G01N33/566

    摘要: We describe a method of monitoring the state of a cell, tissue, organ or organism. The method comprises establishing, for a sample of microparticles from the cell, tissue, organ or organism, a ratio. The ratio is of a selected polypeptide in microparticles which comprise GM1 gangliosides, preferably which bind to Cholera Toxin B (CTB) (“GM1 ganglioside microparticle polypeptide”) to the selected polypeptide in microparticles which comprise exposed phosphotidylserine, preferably which bind to Annexin V (“Annexin V microparticle polypeptide”). The GM1 ganglioside microparticle polypeptide to Annexin V microparticle polypeptide ratio so established may be indicative of the state of the cell, tissue, organ or organism.

    摘要翻译: 我们描述一种监测细胞,组织,器官或生物体状态的方法。 该方法包括对来自细胞,组织,器官或生物体的微粒样品的比例建立一个比例。 该比例是包含GM1神经节苷脂的微粒中所选择的多肽,其优选结合霍乱毒素B(CTB)(“GM1神经节苷脂微粒多肽”)对包含暴露的磷脂酰丝氨酸的微粒中所选择的多肽,优选结合膜联蛋白V( “膜联蛋白V微粒多肽”)。 GM1神经节苷脂微粒多肽对Annexin V微粒多肽的比例如此建立可以指示细胞,组织,器官或生物体的状态。

    BODIPY STRUCTURE FLUORESCENCE PROBES FOR DIVERSE BIOLOGICAL APPLICATIONS
    27.
    发明公开
    BODIPY STRUCTURE FLUORESCENCE PROBES FOR DIVERSE BIOLOGICAL APPLICATIONS 有权
    FLUORESZENZSONDEN MIT BODIPY-STRUKTURFÜRVERSCHIEDENE BIOLOGISCHE ANWENDUNGEN

    公开(公告)号:EP2794620A4

    公开(公告)日:2015-09-02

    申请号:EP12859000

    申请日:2012-12-20

    IPC分类号: C07F5/02 G01N33/533

    摘要: The present invention is directed to a fluorescence compound represented by structural Formula (I), with specificity to neural stem cells: (I), or a pharmaceutically acceptable salt thereof. The variables for structural Formula (I) are defined herein. Also described are methods for detection of beta cells, pancreatic islets and microglia cells, comprising using a compound of structural Formula (I) or pharmaceutically acceptable salts thereof. Compounds of structural Formula (I) can also differentiate healthy pancreatic islet cells from diabetic pancreatic islet cells.

    摘要翻译: 本发明涉及由结构式(I)表示的对神经干细胞特异性的荧光化合物:(I)或其药学上可接受的盐。 结构式(I)的变量在本文中定义。 还描述了用于检测β细胞,胰岛和小神经胶质细胞的方法,包括使用结构式(I)的化合物或其药学上可接受的盐。 结构式(I)的化合物还可以将健康胰岛细胞与糖尿病胰岛细胞分化。